GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Ebrains 6599.T · JPY

Information Technology · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,901

+0.83%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥3.99bn

FY2018FY2026

Net income

¥364.4m

FY2018FY2026

Free cash flow

¥566.8m

FY2018FY2026

Shareholders' equity

¥5.10bn

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue¥3.99bn¥4.03bn¥3.99bn¥4.26bn¥3.92bn¥3.20bn¥3.18bn¥3.31bn¥3.60bn
Gross profit¥921.9m¥864.5m¥911.1m¥1.05bn¥927.6m¥680.5m¥659.0m¥728.7m¥736.1m
Research and development—¥17.5m¥33.5m¥17.2m¥21.2m¥35.7m¥12.2m¥16.3m¥21.7m
Operating income¥530.5m¥464.6m¥486.0m¥656.2m¥537.7m¥298.6m¥283.5m¥364.4m¥345.4m
Net income¥364.4m¥313.4m¥332.1m¥426.2m¥345.4m¥200.2m¥200.3m¥261.2m¥255.3m
Diluted earnings per share241.52207.71220.07282.44228.88132.65132.77173.13169.17

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets¥6.37bn¥5.93bn¥5.70bn¥5.62bn¥5.20bn¥4.59bn¥4.20bn¥4.10bn¥4.19bn
Cash and short-term investments¥2.25bn¥2.73bn¥2.39bn¥1.92bn¥1.75bn¥1.53bn−¥106.0m¥1.13bn¥1.20bn
Total liabilities¥1.26bn¥1.14bn¥1.20bn¥1.43bn¥1.41bn¥1.14bn¥106.0m¥1.20bn¥1.45bn
Debt————¥28.0m¥66.0m¥106.0m¥196.0m¥246.6m
Shareholders' equity¥5.10bn¥4.79bn¥4.50bn¥4.20bn¥3.79bn¥3.45bn¥3.09bn¥2.91bn¥2.73bn
Shares outstanding2m2m2m2m2m2m2m2m2m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations¥570.9m¥382.2m¥505.4m¥247.4m¥268.0m¥152.6m¥276.6m¥86.3m−¥8.4m
Capital spending−¥4.1m−¥2.6m−¥4.3m−¥10.5m−¥4.5m−¥26.4m−¥2.7m−¥27.7m−¥1.8m
Free cash flow¥566.8m¥379.6m¥501.1m¥236.9m¥263.4m¥126.2m¥273.9m¥58.7m−¥10.2m
Dividends paid−¥60.4m−¥57.3m−¥40.7m−¥33.2m−¥27.2m−¥20.5m−¥13.7m−¥14.1m−¥14.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥1.19bn¥1.11bn¥941.3m¥1.02bn¥913.1m¥997.2m¥1.10bn¥910.1m
Gross profit¥315.5m¥266.7m¥216.9m¥226.8m¥211.5m¥223.3m¥238.8m¥178.4m
Operating income¥213.0m¥169.5m¥123.1m¥126.8m¥111.1m¥128.9m¥147.3m¥76.9m
Net income¥136.0m¥111.1m¥83.0m¥94.5m¥75.8m¥82.9m¥105.9m¥53.7m
Diluted earnings per share90.1673.6155.0262.6550.2454.9170.2135.60
Total assets¥6.73bn¥6.37bn¥6.06bn¥5.91bn¥5.97bn¥5.93bn¥5.80bn¥5.61bn
Cash and short-term investments¥2.37bn¥2.25bn¥3.11bn¥2.89bn¥2.80bn¥2.73bn¥2.52bn¥2.38bn
Debt——¥33.0m———¥30.0m—
Shareholders' equity¥5.18bn¥5.10bn¥4.97bn¥4.87bn¥4.79bn¥4.79bn¥4.68bn¥4.61bn

Financial ratios

Data as of 19 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin23.1%21.5%22.8%24.6%23.6%21.3%———
Operating margin13.3%11.5%12.2%15.4%13.7%9.3%———
Net margin9.1%7.8%8.3%10.0%8.8%6.3%———
Return on equity7.1%6.5%7.4%10.2%9.1%5.8%———
Return on assets5.7%5.3%5.8%7.6%6.6%4.4%———
Free cash flow yield9.8%6.6%8.7%4.2%4.6%2.6%———
Revenue growth-0.8%1.0%-6.4%8.6%22.5%0.6%———
Earnings growth16.3%-5.6%-22.1%23.4%72.5%-0.1%———
Current ratio4.87x6.57x5.72x4.27x3.83x4.29x———
Debt to equity———0.00x0.01x0.02x0.03x0.04x0.04x
Equity ratio80.1%80.7%79.0%74.6%72.9%75.1%———
Interest coverage3138.98x5105.47x6567.65x7542.80x1804.21x660.52x———
R&D as a share of sales—0.4%0.8%0.4%0.5%1.1%0.4%——
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.1%4.5%—
Operating income-6.8%12.2%—
Net income-5.1%12.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin22.3%23.0%22.9%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings13.813.110.27.99.919.222.1
Price to sales1.31.00.80.80.91.21.4

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year88.0033.0027.0022.0018.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.